BR112012021556A2 - processo para a preparação de peptídeos prolila substituídos e peptidomiméticos similares - Google Patents

processo para a preparação de peptídeos prolila substituídos e peptidomiméticos similares

Info

Publication number
BR112012021556A2
BR112012021556A2 BR112012021556A BR112012021556A BR112012021556A2 BR 112012021556 A2 BR112012021556 A2 BR 112012021556A2 BR 112012021556 A BR112012021556 A BR 112012021556A BR 112012021556 A BR112012021556 A BR 112012021556A BR 112012021556 A2 BR112012021556 A2 BR 112012021556A2
Authority
BR
Brazil
Prior art keywords
substituted
preparation
nonaromatic
peptidomimetics
compound
Prior art date
Application number
BR112012021556A
Other languages
English (en)
Inventor
Znabet Anass
Ruijter Eelco
Polak Marloes
Turner Nicholas
Orru Romano
Original Assignee
Ver Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patiëntenzorg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ver Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patiëntenzorg filed Critical Ver Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patiëntenzorg
Publication of BR112012021556A2 publication Critical patent/BR112012021556A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/10—Isocyanides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/14—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

processo para a preparação de peptídeos prolila substitutídos e peptidomiméticos similarers. a presente invenção refere-se a um processo para preparação estereosseletiva de um composto de fórmula geral (i) ou seus respectivos diastereômeros: compreendendo reação de um compotso de fómula geral (ii) ou seus diastereômeros: com um composto de fómula geral (iii: r3-cooh (iii) r3-cooh e um composto da fórmula geral iv: r4-nc (iv) r4-nc em que r1 representa cada um, independentemente ou conuntamente, uma estrutura substtiutída ou não substtiutída de alquila, alquenila, alquinila, aromática ou não aromática, mono-, di- ou tricíclica, ou heterocíclica, e r2 representa um átomo de hidrogênio, uma estrutura substituída ou não substituída de alquila, alquenila, alquinila, aromática ou não aromática, mono-, di- ou tricíclica, ou heterocíclica, e r3 representa uma estrutura substituída ou não substituída de alquila, alquinila, ou um aromático ou não aromático ou não aromático, mono-, di- ou tricíclica, ou heterocíclica.
BR112012021556A 2010-02-25 2010-09-16 processo para a preparação de peptídeos prolila substituídos e peptidomiméticos similares BR112012021556A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30787310P 2010-02-25 2010-02-25
PCT/EP2010/063656 WO2011103932A1 (en) 2010-02-25 2010-09-16 A process for the preparation of substituted prolyl peptides and similar peptidomimetics

Publications (1)

Publication Number Publication Date
BR112012021556A2 true BR112012021556A2 (pt) 2017-03-21

Family

ID=43088069

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112012021556A BR112012021556A2 (pt) 2010-02-25 2010-09-16 processo para a preparação de peptídeos prolila substituídos e peptidomiméticos similares
BR112012021581A BR112012021581A2 (pt) 2010-02-25 2010-09-16 processo de preparação de alfa-aciloxil beta-formamido amidas

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112012021581A BR112012021581A2 (pt) 2010-02-25 2010-09-16 processo de preparação de alfa-aciloxil beta-formamido amidas

Country Status (7)

Country Link
US (3) US8686145B2 (pt)
EP (2) EP2539320A1 (pt)
CN (2) CN102844314B (pt)
BR (2) BR112012021556A2 (pt)
CA (2) CA2791045A1 (pt)
MX (2) MX2012009927A (pt)
WO (2) WO2011103933A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735171C (en) * 2008-08-29 2023-10-03 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of p.gingivalis infection
EP2539320A1 (en) * 2010-02-25 2013-01-02 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg A process for the preparation of substituted prolyl peptides and similar peptidomimetics
US8820164B2 (en) * 2012-01-31 2014-09-02 Sikorsky Aircraft Corporation Retroreflector for ultrasonic inspection
ITMI20120359A1 (it) * 2012-03-07 2013-09-08 Dipharma Francis Srl Procedimento per la preparazione di intermedi utili nella preparazione di un inibitore delle proteasi virali
AR091192A1 (es) 2012-05-30 2015-01-21 Chemo Iberica Sa Procedimiento multicomponente para la preparacion de compuestos biciclicos
CN103570605B (zh) * 2012-08-01 2015-08-05 上海迪赛诺药业有限公司 特拉匹韦及其中间体的制备方法
WO2014096374A1 (en) * 2012-12-21 2014-06-26 Sandoz Ag Process for the synthesis of pyrrolidines and pyrroles
WO2014102816A1 (en) * 2012-12-26 2014-07-03 Glenmark Pharmaceuticals Limited; Glenmark Generics Limited Process for preparation of telaprevir and intermediates
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
CN115253696B (zh) * 2021-04-29 2023-09-22 天津膜天膜科技股份有限公司 手性分离膜及其制备方法
PE20240775A1 (es) * 2021-07-09 2024-04-17 Aligos Therapeutics Inc Compuestos antivirales
CN114736882B (zh) * 2022-05-20 2023-09-22 苏州百福安酶技术有限公司 一种单胺氧化酶及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
PL206255B1 (pl) * 2000-07-21 2010-07-30 Dendreon Corporationdendreon Corporation Inhibitor proteazy wirusa zapalenia wątroby C, zawierająca go kompozycja farmaceutyczna i zastosowanie inhibitora do wytwarzania leku do leczenia chorób związanych z HCV oraz zastosowanie do wytwarzania kompozycji do stosowania w kombinowanej terapii
GB0206415D0 (en) 2002-03-19 2002-05-01 Glaxo Group Ltd Deracemisation of amines
WO2005058821A1 (en) * 2003-12-11 2005-06-30 Schering Corporation Inhibitors of hepatitis c virus ns3/ns4a serine protease
JP2008501802A (ja) * 2004-06-08 2008-01-24 バーテックス　ファーマシューティカルズ　インコーポレイテッド 医薬組成物
EP2374464A3 (en) * 2004-10-01 2011-10-26 Vertex Pharmaceuticals Incorporated HCV N3S-NS4A protease inhibition
GB0426661D0 (en) 2004-12-06 2005-01-05 Isis Innovation Pyrrolidine compounds
PL1891089T3 (pl) * 2005-06-02 2015-05-29 Merck Sharp & Dohme Inhibitory proteazy HCV w połączeniu z pokarmem
MX2008002188A (es) 2005-08-18 2008-04-10 Clean Filtration Technologies Inc Sistema de filtrado de liquidos basados en un hidroclon.
JP5203203B2 (ja) * 2005-08-19 2013-06-05 バーテックス ファーマシューティカルズ インコーポレイテッド 製造工程および中間体
CA2728226A1 (en) 2008-06-24 2010-01-21 Codexis, Inc. Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds
EP2539320A1 (en) * 2010-02-25 2013-01-02 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg A process for the preparation of substituted prolyl peptides and similar peptidomimetics

Also Published As

Publication number Publication date
BR112012021581A2 (pt) 2017-03-21
CA2791045A1 (en) 2011-09-01
CA2790930A1 (en) 2011-09-01
MX2012009927A (es) 2012-10-05
WO2011103932A1 (en) 2011-09-01
EP2539334A1 (en) 2013-01-02
CN102844314B (zh) 2015-05-20
CN102844314A (zh) 2012-12-26
US20120329704A1 (en) 2012-12-27
MX2012009926A (es) 2012-10-05
US20120330015A1 (en) 2012-12-27
CN102822147A (zh) 2012-12-12
US20140213788A1 (en) 2014-07-31
EP2539320A1 (en) 2013-01-02
WO2011103933A1 (en) 2011-09-01
US8686145B2 (en) 2014-04-01

Similar Documents

Publication Publication Date Title
BR112012021556A2 (pt) processo para a preparação de peptídeos prolila substituídos e peptidomiméticos similares
BR112013031463A2 (pt) piridina-2-amidas úteis como agonistas de cb2
BR112012007085B8 (pt) processos para a preparação de derivados de benzil-benzeno substituídos com glicopiranosila
ES2570184T3 (es) Compuestos para dirigir la administración de fármacos y potenciar la actividad de ARNip
BR112013000868A2 (pt) derivados de pirazol [1,5a] e tieno [3,2b] pirimidina como modulares de irak4
BRPI0911404A2 (pt) Derivados de pirano, sua preparação e uso dos mesmos em perfumaria
BR112014010644A2 (pt) novos derivados de aril-quinolina
BRPI0606845A2 (pt) derivados de (1,5-difenil-1h-pirazol-3-il)oxadiazol, o respectivo preparo e a respectiva aplicação em terapêutica
BR112013018732A2 (pt) novos derivados de amida de aril-benzocicloalquila
BR112016006262A2 (pt) composto, composição, material de acabamento automotivo interior ou exterior, artigo agrícola, e, métodos para estabilização de um material orgânico e preparação de um composto
CU20090048A7 (es) Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BRPI0814231B8 (pt) derivados de pleuromutilina, seu uso e composição farmacêutica
BR112013008675A2 (pt) métodos e composições para o tratamento de diabetes e dislipidemia
AR066023A1 (es) Compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
BR112015027164A2 (pt) novos compostos com tripla atividade de trombólise, antitrombótica e neutralização de radical, e sua síntese, nanoestrutura e uso
BR112012021135A2 (pt) microbicidas
BR112014015430A8 (pt) formulação oftálmica
SG194727A1 (en) Method for modification of organic molecules
BR112015015229A8 (pt) processo para a preparação de um composto da fórmula, e, composto
BRPI0516994A (pt) processo para preparação de pirazóis
UA111709C2 (uk) Застосування похідних n-бензоїлсерину для запобігання або ослаблення пігментації
EA201270277A1 (ru) N-ацилированные октасахариды, активирующие рецепторы fgf, их получение и применение в терапии
BR112012013005A2 (pt) compostos químicos e seu uso como pesticidas.
BR112013011244A2 (pt) processo para a preparação de derivados e ácido 3-(6-amino-piridin-3il)-2-acrílico
BRPI0518998A2 (pt) âmega-feniloctanamidas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]